Compile Data Set for Download or QSAR
Report error Found 261 Enz. Inhib. hit(s) with all data for entry = 751
TargetMAP kinase-interacting serine/threonine-protein kinase 2(Human)
Evotec Internatonal

US Patent
LigandPNGBDBM289125(US10093660, Example 1.6)
Affinity DataIC50: 1nMT: 2°CAssay Description:ASSAY SETUP: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purch...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMAP kinase-interacting serine/threonine-protein kinase 2(Human)
Evotec Internatonal

US Patent
LigandPNGBDBM289150(US10093660, Example 1.22)
Affinity DataIC50: 1nMT: 2°CAssay Description:ASSAY SETUP: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purch...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMAP kinase-interacting serine/threonine-protein kinase 2(Human)
Evotec Internatonal

US Patent
LigandPNGBDBM289169(US10093660, Example 2.2 | US10093660, Example 14.1)
Affinity DataIC50: 1nMT: 2°CAssay Description:ASSAY SETUP: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purch...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMAP kinase-interacting serine/threonine-protein kinase 2(Human)
Evotec Internatonal

US Patent
LigandPNGBDBM289396(US10093660, Example 10.1)
Affinity DataIC50: 1nMT: 2°CAssay Description:ASSAY SETUP: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purch...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMAP kinase-interacting serine/threonine-protein kinase 2(Human)
Evotec Internatonal

US Patent
LigandPNGBDBM289177(US10093660, Example 2.9 | US10093660, Example 14.8)
Affinity DataIC50: 1nMT: 2°CAssay Description:ASSAY SETUP: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purch...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMAP kinase-interacting serine/threonine-protein kinase 2(Human)
Evotec Internatonal

US Patent
LigandPNGBDBM289164(US10093660, Example 1.35)
Affinity DataIC50: 1nMT: 2°CAssay Description:ASSAY SETUP: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purch...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMAP kinase-interacting serine/threonine-protein kinase 2(Human)
Evotec Internatonal

US Patent
LigandPNGBDBM289370(US10093660, Example 9.5)
Affinity DataIC50: 1nMT: 2°CAssay Description:ASSAY SETUP: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purch...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMAP kinase-interacting serine/threonine-protein kinase 2(Human)
Evotec Internatonal

US Patent
LigandPNGBDBM289126(US10093660, Example 1.7)
Affinity DataIC50: 2nMT: 2°CAssay Description:ASSAY SETUP: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purch...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMAP kinase-interacting serine/threonine-protein kinase 2(Human)
Evotec Internatonal

US Patent
LigandPNGBDBM289127(US10093660, Example 1.8)
Affinity DataIC50: 2nMT: 2°CAssay Description:ASSAY SETUP: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purch...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMAP kinase-interacting serine/threonine-protein kinase 2(Human)
Evotec Internatonal

US Patent
LigandPNGBDBM289131(US10093660, Example 1.9)
Affinity DataIC50: 2nMT: 2°CAssay Description:ASSAY SETUP: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purch...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMAP kinase-interacting serine/threonine-protein kinase 2(Human)
Evotec Internatonal

US Patent
LigandPNGBDBM289196(US10093660, Example 2.25)
Affinity DataIC50: 2nMT: 2°CAssay Description:ASSAY SETUP: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purch...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMAP kinase-interacting serine/threonine-protein kinase 2(Human)
Evotec Internatonal

US Patent
LigandPNGBDBM289299(US10093660, Example 2.92)
Affinity DataIC50: 2nMT: 2°CAssay Description:ASSAY SETUP: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purch...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMAP kinase-interacting serine/threonine-protein kinase 2(Human)
Evotec Internatonal

US Patent
LigandPNGBDBM289200(US10093660, Example 2.29)
Affinity DataIC50: 2nMT: 2°CAssay Description:ASSAY SETUP: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purch...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMAP kinase-interacting serine/threonine-protein kinase 2(Human)
Evotec Internatonal

US Patent
LigandPNGBDBM289123(US10093660, Example 1.4)
Affinity DataIC50: 2nMT: 2°CAssay Description:ASSAY SETUP: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purch...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMAP kinase-interacting serine/threonine-protein kinase 2(Human)
Evotec Internatonal

US Patent
LigandPNGBDBM289124(US10093660, Example 1.5 | US10093660, Example 14.1...)
Affinity DataIC50: 2nMT: 2°CAssay Description:ASSAY SETUP: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purch...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMAP kinase-interacting serine/threonine-protein kinase 2(Human)
Evotec Internatonal

US Patent
LigandPNGBDBM289153(US10093660, Example 1.25)
Affinity DataIC50: 2nMT: 2°CAssay Description:ASSAY SETUP: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purch...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMAP kinase-interacting serine/threonine-protein kinase 2(Human)
Evotec Internatonal

US Patent
LigandPNGBDBM289157(US10093660, Example 1.29)
Affinity DataIC50: 2nMT: 2°CAssay Description:ASSAY SETUP: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purch...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMAP kinase-interacting serine/threonine-protein kinase 2(Human)
Evotec Internatonal

US Patent
LigandPNGBDBM289250(US10093660, Example 2.56)
Affinity DataIC50: 2nMT: 2°CAssay Description:ASSAY SETUP: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purch...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMAP kinase-interacting serine/threonine-protein kinase 2(Human)
Evotec Internatonal

US Patent
LigandPNGBDBM289412(US10093660, Example 14.4)
Affinity DataIC50: 2nMT: 2°CAssay Description:ASSAY SETUP: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purch...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMAP kinase-interacting serine/threonine-protein kinase 2(Human)
Evotec Internatonal

US Patent
LigandPNGBDBM289220(US10093660, Example 2.41)
Affinity DataIC50: 2nMT: 2°CAssay Description:ASSAY SETUP: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purch...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMAP kinase-interacting serine/threonine-protein kinase 2(Human)
Evotec Internatonal

US Patent
LigandPNGBDBM289397(US10093660, Example 10.2)
Affinity DataIC50: 2nMT: 2°CAssay Description:ASSAY SETUP: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purch...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMAP kinase-interacting serine/threonine-protein kinase 2(Human)
Evotec Internatonal

US Patent
LigandPNGBDBM289144(US10093660, Example 1.16)
Affinity DataIC50: 2nMT: 2°CAssay Description:ASSAY SETUP: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purch...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMAP kinase-interacting serine/threonine-protein kinase 2(Human)
Evotec Internatonal

US Patent
LigandPNGBDBM289145(US10093660, Example 1.17)
Affinity DataIC50: 2nMT: 2°CAssay Description:ASSAY SETUP: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purch...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMAP kinase-interacting serine/threonine-protein kinase 2(Human)
Evotec Internatonal

US Patent
LigandPNGBDBM289146(US10093660, Example 1.18)
Affinity DataIC50: 2nMT: 2°CAssay Description:ASSAY SETUP: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purch...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMAP kinase-interacting serine/threonine-protein kinase 2(Human)
Evotec Internatonal

US Patent
LigandPNGBDBM289148(US10093660, Example 1.20)
Affinity DataIC50: 2nMT: 2°CAssay Description:ASSAY SETUP: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purch...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMAP kinase-interacting serine/threonine-protein kinase 2(Human)
Evotec Internatonal

US Patent
LigandPNGBDBM289176(US10093660, Example 14.6 | US10093660, Example 2.8)
Affinity DataIC50: 2nMT: 2°CAssay Description:ASSAY SETUP: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purch...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMAP kinase-interacting serine/threonine-protein kinase 2(Human)
Evotec Internatonal

US Patent
LigandPNGBDBM289252(US10093660, Example 2.58)
Affinity DataIC50: 2nMT: 2°CAssay Description:ASSAY SETUP: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purch...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMAP kinase-interacting serine/threonine-protein kinase 2(Human)
Evotec Internatonal

US Patent
LigandPNGBDBM289176(US10093660, Example 14.6 | US10093660, Example 2.8)
Affinity DataIC50: 2nMT: 2°CAssay Description:ASSAY SETUP: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purch...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMAP kinase-interacting serine/threonine-protein kinase 2(Human)
Evotec Internatonal

US Patent
LigandPNGBDBM289124(US10093660, Example 1.5 | US10093660, Example 14.1...)
Affinity DataIC50: 2nMT: 2°CAssay Description:ASSAY SETUP: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purch...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMAP kinase-interacting serine/threonine-protein kinase 2(Human)
Evotec Internatonal

US Patent
LigandPNGBDBM289257(US10093660, Example 2.63)
Affinity DataIC50: 2nMT: 2°CAssay Description:ASSAY SETUP: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purch...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMAP kinase-interacting serine/threonine-protein kinase 2(Human)
Evotec Internatonal

US Patent
LigandPNGBDBM289178(US10093660, Example 2.10)
Affinity DataIC50: 2nMT: 2°CAssay Description:ASSAY SETUP: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purch...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMAP kinase-interacting serine/threonine-protein kinase 2(Human)
Evotec Internatonal

US Patent
LigandPNGBDBM289366(US10093660, Example 9.1)
Affinity DataIC50: 2nMT: 2°CAssay Description:ASSAY SETUP: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purch...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMAP kinase-interacting serine/threonine-protein kinase 2(Human)
Evotec Internatonal

US Patent
LigandPNGBDBM289367(US10093660, Example 9.2)
Affinity DataIC50: 2nMT: 2°CAssay Description:ASSAY SETUP: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purch...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMAP kinase-interacting serine/threonine-protein kinase 2(Human)
Evotec Internatonal

US Patent
LigandPNGBDBM289315(US10093660, Example 2.99)
Affinity DataIC50: 3nMT: 2°CAssay Description:ASSAY SETUP: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purch...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMAP kinase-interacting serine/threonine-protein kinase 2(Human)
Evotec Internatonal

US Patent
LigandPNGBDBM289213(US10093660, Example 2.36)
Affinity DataIC50: 3nMT: 2°CAssay Description:ASSAY SETUP: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purch...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMAP kinase-interacting serine/threonine-protein kinase 2(Human)
Evotec Internatonal

US Patent
LigandPNGBDBM289215(US10093660, Example 2.38)
Affinity DataIC50: 3nMT: 2°CAssay Description:ASSAY SETUP: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purch...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMAP kinase-interacting serine/threonine-protein kinase 2(Human)
Evotec Internatonal

US Patent
LigandPNGBDBM289394(US10093660, Example 9.29)
Affinity DataIC50: 3nMT: 2°CAssay Description:ASSAY SETUP: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purch...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMAP kinase-interacting serine/threonine-protein kinase 2(Human)
Evotec Internatonal

US Patent
LigandPNGBDBM289197(US10093660, Example 2.26)
Affinity DataIC50: 3nMT: 2°CAssay Description:ASSAY SETUP: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purch...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMAP kinase-interacting serine/threonine-protein kinase 2(Human)
Evotec Internatonal

US Patent
LigandPNGBDBM289122(US10093660, Example 1.3)
Affinity DataIC50: 3nMT: 2°CAssay Description:ASSAY SETUP: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purch...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMAP kinase-interacting serine/threonine-protein kinase 2(Human)
Evotec Internatonal

US Patent
LigandPNGBDBM289405(US10093660, Example 12.2)
Affinity DataIC50: 3nMT: 2°CAssay Description:ASSAY SETUP: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purch...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMAP kinase-interacting serine/threonine-protein kinase 2(Human)
Evotec Internatonal

US Patent
LigandPNGBDBM289152(US10093660, Example 1.24)
Affinity DataIC50: 3nMT: 2°CAssay Description:ASSAY SETUP: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purch...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMAP kinase-interacting serine/threonine-protein kinase 2(Human)
Evotec Internatonal

US Patent
LigandPNGBDBM289154(US10093660, Example 1.26)
Affinity DataIC50: 3nMT: 2°CAssay Description:ASSAY SETUP: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purch...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMAP kinase-interacting serine/threonine-protein kinase 2(Human)
Evotec Internatonal

US Patent
LigandPNGBDBM289155(US10093660, Example 1.27)
Affinity DataIC50: 3nMT: 2°CAssay Description:ASSAY SETUP: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purch...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMAP kinase-interacting serine/threonine-protein kinase 2(Human)
Evotec Internatonal

US Patent
LigandPNGBDBM289248(US10093660, Example 2.54)
Affinity DataIC50: 3nMT: 2°CAssay Description:ASSAY SETUP: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purch...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMAP kinase-interacting serine/threonine-protein kinase 2(Human)
Evotec Internatonal

US Patent
LigandPNGBDBM289249(US10093660, Example 2.55)
Affinity DataIC50: 3nMT: 2°CAssay Description:ASSAY SETUP: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purch...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMAP kinase-interacting serine/threonine-protein kinase 2(Human)
Evotec Internatonal

US Patent
LigandPNGBDBM289143(US10093660, Example 1.15)
Affinity DataIC50: 3nMT: 2°CAssay Description:ASSAY SETUP: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purch...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMAP kinase-interacting serine/threonine-protein kinase 2(Human)
Evotec Internatonal

US Patent
LigandPNGBDBM289398(US10093660, Example 10.3)
Affinity DataIC50: 3nMT: 2°CAssay Description:ASSAY SETUP: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purch...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMAP kinase-interacting serine/threonine-protein kinase 2(Human)
Evotec Internatonal

US Patent
LigandPNGBDBM289225(US10093660, Example 2.43)
Affinity DataIC50: 3nMT: 2°CAssay Description:ASSAY SETUP: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purch...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMAP kinase-interacting serine/threonine-protein kinase 2(Human)
Evotec Internatonal

US Patent
LigandPNGBDBM289399(US10093660, Example 10.4)
Affinity DataIC50: 3nMT: 2°CAssay Description:ASSAY SETUP: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purch...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

TargetMAP kinase-interacting serine/threonine-protein kinase 2(Human)
Evotec Internatonal

US Patent
LigandPNGBDBM289239(US10093660, Example 2.47 | US10093660, Example 2.4...)
Affinity DataIC50: 3nMT: 2°CAssay Description:ASSAY SETUP: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purch...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/22/2019
Entry Details
US Patent

Displayed 1 to 50 (of 261 total ) | Next | Last >>
Jump to: